Shenbai Granules for Preventing Malignant Transformation of High-risk Colorectal Adenomas

NANot yet recruitingINTERVENTIONAL
Enrollment

450

Participants

Timeline

Start Date

August 15, 2025

Primary Completion Date

November 30, 2028

Study Completion Date

November 30, 2028

Conditions
Colorectal AdenomaHigh RiskTCM
Interventions
DRUG

Shenbai Granules

10 g/bag, two bags each time, twice a day, monthly for 30 days for 6 months.

DRUG

Placebo

10 g/bag, two bags each time, twice a day, monthly for 30 days for 6 months.

Trial Locations (1)

Unknown

Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing

All Listed Sponsors
collaborator

The First Affiliated Hospital with Nanjing Medical University

OTHER

collaborator

First Affiliated Hospital of Harbin Medical University

OTHER

collaborator

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

OTHER

collaborator

The Second Affiliated Hospital of Chongqing Medical University

OTHER

collaborator

Chongqing Traditional Chinese Medicine Hospital

OTHER

collaborator

The Second Hospital of Shandong University

OTHER

collaborator

Shengjing Hospital

OTHER

collaborator

Shenzhen Hospital of Southern Medical University

OTHER

collaborator

Sixth Affiliated Hospital, Sun Yat-sen University

OTHER

collaborator

Sichuan Provincial People's Hospital

OTHER

collaborator

Shanxi Provincial People's Hospital

OTHER_GOV

collaborator

Affiliated Hospital of Nanjing University of Chinese Medicine

OTHER

collaborator

RenJi Hospital

OTHER

lead

Jiangsu Famous Medical Technology Co., Ltd.

INDUSTRY